info@australianvisionresearch.org

DONATE NOW

Australian Vision Research
  • About
    • About
    • Contact
    • News
  • Grants
  • Excellence Awards
  • Research
  • AVR Insights
  • Members
  • AVR Bequest Program
  • Donate
Targeting inflammation to prevent age-related macular degeneration

Targeting inflammation to prevent age-related macular degeneration

by AVR Supporters | Feb 1, 2021 | Research

Dr Nilisha Fernando, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT Age-Related Macular Degeneration (AMD) is the leading cause of vision loss in the Western world. “There are two forms of the disease, ‘wet’...
Glaucoma gene therapy: protecting cells to prevent vision loss

Glaucoma gene therapy: protecting cells to prevent vision loss

by AVR Supporters | Feb 1, 2021 | Research

Dr Mark Hassall, Flinders Centre for Ophthalmology, Eye and Vision Research School of Medicine, Flinders University, South Australia Glaucoma is a leading cause of irreversible blindness and affects an estimated 80 million people worldwide. Glaucoma affects the...
Developing a sight-saving drug for retinal detachment

Developing a sight-saving drug for retinal detachment

by AVR Supporters | Feb 1, 2021 | Research

Dr WengOnn Chan, Ophthalmic Research Laboratories, Ophthalmology Network, Royal Adelaide Hospital, University of Adelaide, South Australia Retinal detachment is a common ophthalmic condition and causes blindness if left untreated. This is because the blood supply is...
How does ultraviolet light from the sun damage the eye?

How does ultraviolet light from the sun damage the eye?

by AVR Supporters | Feb 1, 2021 | Research

Prof Stephanie Watson, Save Sight Institute, University of Sydney, Sydney, NSW This study will investigate the cellular mechanisms for ultraviolet radiation damage to the cornea. Ultraviolet radiation from the sun causes common eye disorders, such as pterygium, and...
Gaining a better understanding of optic nerve damage in MS and neuromyolitis optica (NMO)

Gaining a better understanding of optic nerve damage in MS and neuromyolitis optica (NMO)

by AVR Supporters | Feb 1, 2021 | Research

Dr Yuyi You, Save Sight Institute, University of Sydney, Sydney, NSW Neuromyelitis optica (NMO) and multiple sclerosis (MS) are autoimmune conditions that cause a loss of myelin, the insulating layer around nerves. In both diseases the visual system and the optic...
Steps towards gene therapy for diabetic retinopathy

Steps towards gene therapy for diabetic retinopathy

by AVR Supporters | Feb 1, 2021 | Research

Dr Guei-Sheung Liu, Menzies Institute for Medical Research, University of Tasmania, Tasmania Diabetic retinopathy is a frequent complication of diabetes and is a leading cause of vision loss worldwide. Treatments for diabetic retinopathy include anti-VEGF treatments...
« Older Entries
Next Entries »

Recent Posts

  • Identifying cardiovascular disease parameters with high clinical relevance in primary open-angle glaucoma
  • Grants Round 2025 Open
  • Amyloid and Tau targeting to protect Retinal Ganglion Cell and Optic Nerve in glaucoma
  • Targeting Nrf2-MAFF pathway in Müller cells to treat macular degeneration
  • CEO Attends Sohn Hearts & Minds Conference in Adelaide

Recent Comments

No comments to show.
Australian Vision Research

© Copyright 2024 Australian Vision Research ABN 37008393146

About
Grants
Research
News
Members
Contact

CONTACT US

PO BOX 3109
Erina NSW 2250
 

For all enquiries contact us on

info@australianvisionresearch.org

Privacy Policy

  • Follow
  • Follow
  • Follow
  • Follow

Australian Vision Research conforms to the highest corporate governance standards with its fully audited annual financial statements and reports publicly available.